Back to search

Article

Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms

2024-11-01

Abstract excerpt

Chronic pain affects 20-30% of the population and imposes a significant socio-economic burden as it is often accompanied by substantial emotional comorbidities such as anxiety and depression. Yet, the mechanisms underlying the interactions between the sensory and emotional aspects of chronic pain remain poorly understood. Here, we investigated the role of FKBP51, a regulator of the stress response, in mediating bo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f2aae96-da1a-59e5-838d-cc87d9da00be
DOI
10.1101/2024.11.01.621278
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptomsDOI 10.1101/2024.11.01.621278
Select a neighboring publication to make it the new centre.